Global Subcutaneous Drug Delivery Devices Market to Reach $39.57 Billion by 2029, Growing at 7.4% CAGR

What industry-specific factors are fueling the growth of the subcutaneous drug delivery devices market?
The subcutaneous drug delivery devices market is projected to expand due to the rising incidence of diabetes and cardiovascular diseases. Factors such as an aging population, unhealthy eating, a sedentary lifestyle, obesity, social economic disparities, stress, environmental issues, and limited preventive healthcare access contribute to the increased occurrence of these diseases. Diabetes and cardiovascular disease management often involves subcutaneous drug delivery devices to deliver insulin and other medications for blood sugar regulation or drugs such as anticoagulants or lipid-reducing agents. For instance, new data from the British Diabetic Association disclosed in April 2023 shows that 4.3 million UK residents are currently living with a diabetes diagnosis. This figure represents an increase of 148,951 registered cases from 2020-21 to 2021-22, with more than 2.4 million individuals in the UK being at high risk of developing type 2 diabetes. Additionally, in May 2024, according to the US-based Centers for Disease Control and Prevention, heart disease was responsible for the deaths of 702,880 individuals in 2022, which amounts to one in every five deaths. As a result, the growing rate of diabetes and cardiovascular diseases (CVD) is fueling the demand for subcutaneous drug delivery devices in the market.

Get Your Subcutaneous Drug Delivery Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report

What Is the projected market size and growth rate for the subcutaneous drug delivery devices market?
The market size for subcutaneous drug delivery devices has experienced robust growth in recent times. It is estimated to expand from its 2024 value of $27.66 billion, reaching $29.77 billion in 2025 with a compound annual growth rate (CAGR) of 7.6%. The factors that contributed to the growth in the historical period include the rising occurrence of chronic illnesses, the growing need for self-administration of medications, an increase in diabetes and obesity rates, the preference of patients for convenient therapies, and the increasing population of the elderly.

The market size of subcutaneous drug delivery devices is projected to witness robust growth in the coming years, reaching $39.57 billion in 2029 with a CAGR of 7.4%. Several factors contributing to this growth in the forecasted period include expansion in the biologics and biosimilars market, increased usage of wearable drug delivery systems, growth of personalized medicine, enhancements in healthcare reimbursement policies, and a rising focus on home healthcare. Key trends expected in the forecast period consist of the incorporation of digital health technologies, the creation of smart and interconnected devices, the surge in minimally invasive procedures, progress in needle-free injection systems, and the advent of artificial intelligence in device development.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp

What new trends are reshaping the subcutaneous drug delivery devices market and its opportunities?
Leading corporations in the subcutaneous drug delivery devices market are prioritizing the creation of innovative products like petite digital liquid flow sensors. The ultimate goal is to improve the safety and accuracy of subcutaneous drug administration by employing precise, tailor-made flow sensors for high-volume injectors. These petite digital liquid flow sensors are small devices that diligently measure the liquid flow rate in petite-size applications, delivering digital information for precise monitoring and management. To cite an example, Sensirion AG, a global flow and environmental sensor provider from Switzerland, launched the SLD3x series sensor platform in May 2024. This sensor series includes remarkably precise digital liquid flow sensors offering custom solutions. It delivers precision in flow measurement, occlusion detection, aliasing of air bubbles in-line, and liquid temperature observation. These petite sensors are best suited for large-scale medical device production, ensuring ideal dosage and amplified patient safety in subcutaneous drug administration.

What major market segments define the scope and growth of the subcutaneous drug delivery devices market?
The subcutaneous drug delivery devicesmarket covered in this report is segmented -

1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers

Subsegments:
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) Pen Needles: Standard Pen Needles, Safety Pen Needles
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723

Which regions are key players in the growth of the subcutaneous drug delivery devices market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the subcutaneous drug delivery devices industry growth?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19723&type=smp

What Is Covered In The Subcutaneous Drug Delivery Devices Global Market Report?

•Market Size Forecast: Examine the subcutaneous drug delivery devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the subcutaneous drug delivery devices market for a structured understanding.
•Key Players Overview: Analyze major players in the subcutaneous drug delivery devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the subcutaneous drug delivery devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the subcutaneous drug delivery devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the subcutaneous drug delivery devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the subcutaneous drug delivery devices market.
•Competitive Landscape: Review strategic developments in the subcutaneous drug delivery devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.